Evaluation of CP-99,219, a new fluoroquinolone, for treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis.

CP-99,219 is a new fluoroquinolone that has excellent activity against gram-positive organisms including penicillin- and cephalosporin-resistant Streptococcus pneumoniae strains. In our well-established rabbit model of meningitis, we conducted experiments to determine the concentrations of CP-99,219...

Ful tanımlama

Detaylı Bibliyografya

Yayımlandı:	Antimicrob Agents Chemother
Asıl Yazarlar:	París, M M, Hickey, S M, Trujillo, M, Shelton, S, McCracken, G H
Materyal Türü:	Artigo
Dil:	Inglês
Baskı/Yayın Bilgisi:	American Society for Microbiology (ASM) 1995
Konular:	Research Article
Online Erişim:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC162720/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7574509/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.39.6.1243
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!